Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ACOR - Acorda Therapeutic to receive $15M milestone payment from Biogen


ACOR - Acorda Therapeutic to receive $15M milestone payment from Biogen

Acorda Therapeutic (ACOR) jumps 69% in pre-market trading, as it announces receiving a $15M milestone payment from Biogen International GmbH.The payment is with respect to Acorda’s license agreement with Biogen, based on Biogen’s ex-U.S. net sales of Fampyra exceeding $100M over the four consecutive quarters ending with 3Q20.Acorda to retain ~$14M of the milestone payment net of the Company’s payment obligations to another party.The payment is expected by the end of October 2020.

For further details see:

Acorda Therapeutic to receive $15M milestone payment from Biogen
Stock Information

Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com

Menu

ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...